Bladder cancer is the sixth most common cancer diagnosed in the United States.1 It is the fourth most common cancer in men and the twelfth most common cancer in women.1 According to the American Cancer Society, approximately 81,180 new cases of bladder cancer (61,700 men and 19,480 women) will be diagnosed in the United States in 2022, and approximately 17,100 individuals (12,120 men and 4980 women) will die from the disease.2,3 How much do you know about bladder cancer?
The most common type of bladder cancer is urothelial carcinoma, also known as transitional cell carcinoma, which begins in the urothelial cells that line the inner part of the bladder.1,2 Transitional cell carcinoma can be divided into low-grade or high-grade disease, with the latter being diagnosed in approximately 30% of patients.4 Bladder cancer is most frequently diagnosed in individuals aged >55 years, with approximately 49% of all cases being diagnosed in situ.3 The incidence rate for bladder cancer is 4 times higher in men than in women and 2 times higher in White men than in Black men.3 Although the mortality rate for bladder cancer has declined by 1.7% per year from 2015 to 2019, the 5-year relative survival rate for all stages of the disease combined is 77%, with rates of 96%, 69%, 37%, and 6% for in situ, localized, regional, and distant disease, respectively.2,3 Public awareness of bladder cancer needs to remain a priority to increase survival rates and improve patient quality of life.
To sign up for our newsletter or print publications, please enter your contact information below.
